The Hale Family Center for Pancreatic Cancer Research at Dana-Farber, co-directed by Brian Wolpin, MD, MPH, and Andrew Aguirre, MD, PhD, is fueling a pioneering effort to address challenges in pancreatic cancer prevention, early detection, diagnosis, and treatment.
The Hale Family Center for Pancreatic Cancer Research is dedicated to accelerating the translation of discoveries from the lab to the clinic to improve care and outcomes for patients with pancreatic cancers. We believe that progress in this difficult disease depends on deep collaboration between world-class researchers and clinicians with a breadth of expertise. The Hale Center fosters collaboration both internally, among our 20 Dana-Farber investigators and laboratories, and externally, with academic and industry partners within Boston’s biomedical community and around the world.
The Hale Family Center for Pancreatic Cancer Research brings together leading experts to advance pancreatic cancer research across several key areas:
The Hale Center was established through a generous donation from the Hale Family. In 2007, the Robert T. Hale Sr. and Judith B. Hale Fund for Pancreatic Cancer Research was established, marking the beginning of the Hale Family’s long legacy of support. In the years that followed, the family’s visionary philanthropy led to the creation of the Hale Family Research Center at Dana-Farber and the Robert T. and Judith B. Hale Chair in Pancreatic Cancer at Dana-Farber, currently held by Dr. Wolpin.
The work being done in the Hale Center is already transforming our understanding of the biology driving this disease. The Center is driving a concerted, multidisciplinary effort that has already led to substantial advances in understanding the molecular basis for pancreatic cancer and in developing novel therapies.
Brian M. Wolpin, MD, MPH
Andrew Aguirre, MD, PhD
Sara Buhrlage, PhD
James Cleary, MD, PhD
Stephanie K. Dougan, PhD
William Freed-Pastor, MD, PhD
William C. Hahn, MD, PhD
Kevin M. Haigis, PhD
Brandon Huffman, MD
Joseph D. Mancias, MD, PhD
Franziska Michor, PhD
Sahar Nissim, MD, PhD
Jonathan Nowak, MD, PhD
Kimberly Perez, MD
Michael Rosenthal, MD, PhD
Srivatsan Raghavan, MD, PhD
Rishi Surana, MD, PhD
Eliezer M. Van Allen, MD
Matthew Vander Heiden, MD, PhD
Matthew B. Yurgelun, MD, CGAF, FASCO
Read more about the Hale Center's investigators, research efforts, and discoveries.
Dana-Farber Brigham Cancer Center is the first center in New England to offer magnetic resonance imaging or MRI-guided radiation therapy technologies. This video explores what that means for pancreatic cancer patients.
